BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25551305)

  • 21. The role of RhD agglutination for the detection of weak D red cells by anti-D flow cytometry.
    Grey DE; Davies JI; Connolly M; Fong EA; Erber WN
    Clin Lab Haematol; 2005 Apr; 27(2):127-33. PubMed ID: 15784128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
    Moise KJ
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.
    Tormey CA; Fisk J; Stack G
    Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Massive antenatal fetomaternal hemorrhage: evidence for long-term survival of fetal red blood cells.
    Dziegiel MH; Koldkjaer O; Berkowicz A
    Transfusion; 2005 Apr; 45(4):539-44. PubMed ID: 15819674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A RhD negative patient failed to produce detectable anti-D after transfusion of 35 units of RhD positive red blood cells].
    Lee WM; Kim JH; Ha JS; Ryoo NH; Jeon DS; Kim JR; Cho D
    Korean J Lab Med; 2007 Oct; 27(5):369-72. PubMed ID: 18094603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitation of fetomaternal haemorrhage and F cells in unusual maternal blood samples by flow cytometry using anti-D and anti-HbF.
    Kumpel BM; MacDonald AP; Bishop DR; Yates AF; Lee E
    Transfus Med; 2013 Jun; 23(3):175-86. PubMed ID: 23578132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study.
    Azarkeivan A; Ansari S; Ahmadi MH; Hajibeigy B; Maghsudlu M; Nasizadeh S; Shaigan M; Toolabi A; Salahmand M
    Pediatr Hematol Oncol; 2011 Sep; 28(6):479-85. PubMed ID: 21854216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between maternal antibody type and antenatal course following intrauterine transfusion for red cell alloimmunisation.
    Walsh CA; Russell N; McAuliffe FM; Higgins S; Mahony R; Carroll S; McParland P
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):235-9. PubMed ID: 24075591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fetomaternal hemorrhage following funipuncture: increase in severity of maternal red-cell alloimmunization.
    Bowman JM; Pollock JM; Peterson LE; Harman CR; Manning FA; Menticoglou SM
    Obstet Gynecol; 1994 Nov; 84(5):839-43. PubMed ID: 7936523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Red-cell and platelet alloimmunisation in pregnancy.
    Egbor M; Knott P; Bhide A
    Best Pract Res Clin Obstet Gynaecol; 2012 Feb; 26(1):119-32. PubMed ID: 22119066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pregnant women alloimmunisation of non-RhD erythrocyte antigens: review article].
    Petros M; L'ubuský M; Simetka O; Procházka M
    Ceska Gynekol; 2010 Aug; 75(4):325-33. PubMed ID: 20925232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The assessment of feto-maternal hemorrhage in an artificial model using anti-D and anti-fetal hemoglobin antibody by flow cytometry.
    Pourazar A; Homayouni V; Rezaei A; Andalib A; Oreizi F
    Iran Biomed J; 2008 Jan; 12(1):43-8. PubMed ID: 18392094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of haemoglobin F detection by the acid elution test, flow cytometry and high-performance liquid chromatography in maternal blood samples analysed for fetomaternal haemorrhage.
    Chambers E; Davies L; Evans S; Birchall J; Kumpel B
    Transfus Med; 2012 Jun; 22(3):199-204. PubMed ID: 22429383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of irregular erythrocyte antibodies among antenatal women in Delhi.
    Pahuja S; Gupta SK; Pujani M; Jain M
    Blood Transfus; 2011 Oct; 9(4):388-93. PubMed ID: 21839025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A correlation between severe haemolytic disease of the fetus and newborn and maternal ABO blood group.
    Doyle B; Quigley J; Lambert M; Crumlish J; Walsh C; McParland P; Culliton M; Murphy K; Fitzgerald J
    Transfus Med; 2014 Aug; 24(4):239-43. PubMed ID: 24975587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetomaternal hemorrhage in women undergoing elective cesarean section.
    Perslev A; Jørgensen FS; Nielsen LK; Berkowicz A; Dziegiel MH
    Acta Obstet Gynecol Scand; 2011 Mar; 90(3):253-7. PubMed ID: 21306311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
    Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. O-negative blood shortage management in a university hospital: Impact of transfusing RhD-positive red blood cells to RhD-negative patients.
    Luyten U; Peeraer S; Pirlet C; Khaouch Y; Streel C; Deneys V
    Transfus Clin Biol; 2023 Nov; 30(4):402-409. PubMed ID: 37453488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.